1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Retinal Disorders Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Gels 1.2.3 Ointments 1.2.4 Capsules & Tablets 1.2.5 Eye Drops 1.3 Market by Application 1.3.1 Global Retinal Disorders Treatment Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Macular Degeneration 1.3.3 Diabetic Retinopathy 1.3.4 Diabetic Macular Edema 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Retinal Disorders Treatment Market Perspective (2018-2029) 2.2 Retinal Disorders Treatment Growth Trends by Region 2.2.1 Global Retinal Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Retinal Disorders Treatment Historic Market Size by Region (2018-2023) 2.2.3 Retinal Disorders Treatment Forecasted Market Size by Region (2024-2029) 2.3 Retinal Disorders Treatment Market Dynamics 2.3.1 Retinal Disorders Treatment Industry Trends 2.3.2 Retinal Disorders Treatment Market Drivers 2.3.3 Retinal Disorders Treatment Market Challenges 2.3.4 Retinal Disorders Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Retinal Disorders Treatment Players by Revenue 3.1.1 Global Top Retinal Disorders Treatment Players by Revenue (2018-2023) 3.1.2 Global Retinal Disorders Treatment Revenue Market Share by Players (2018-2023) 3.2 Global Retinal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Retinal Disorders Treatment Revenue 3.4 Global Retinal Disorders Treatment Market Concentration Ratio 3.4.1 Global Retinal Disorders Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Treatment Revenue in 2022 3.5 Retinal Disorders Treatment Key Players Head office and Area Served 3.6 Key Players Retinal Disorders Treatment Product Solution and Service 3.7 Date of Enter into Retinal Disorders Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Retinal Disorders Treatment Breakdown Data by Type 4.1 Global Retinal Disorders Treatment Historic Market Size by Type (2018-2023) 4.2 Global Retinal Disorders Treatment Forecasted Market Size by Type (2024-2029) 5 Retinal Disorders Treatment Breakdown Data by Application 5.1 Global Retinal Disorders Treatment Historic Market Size by Application (2018-2023) 5.2 Global Retinal Disorders Treatment Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Retinal Disorders Treatment Market Size (2018-2029) 6.2 North America Retinal Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Retinal Disorders Treatment Market Size by Country (2018-2023) 6.4 North America Retinal Disorders Treatment Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Retinal Disorders Treatment Market Size (2018-2029) 7.2 Europe Retinal Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Retinal Disorders Treatment Market Size by Country (2018-2023) 7.4 Europe Retinal Disorders Treatment Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Retinal Disorders Treatment Market Size (2018-2029) 8.2 Asia-Pacific Retinal Disorders Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Retinal Disorders Treatment Market Size by Region (2018-2023) 8.4 Asia-Pacific Retinal Disorders Treatment Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Retinal Disorders Treatment Market Size (2018-2029) 9.2 Latin America Retinal Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Retinal Disorders Treatment Market Size by Country (2018-2023) 9.4 Latin America Retinal Disorders Treatment Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Retinal Disorders Treatment Market Size (2018-2029) 10.2 Middle East & Africa Retinal Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Retinal Disorders Treatment Market Size by Country (2018-2023) 10.4 Middle East & Africa Retinal Disorders Treatment Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Allergan plc 11.1.1 Allergan plc Company Detail 11.1.2 Allergan plc Business Overview 11.1.3 Allergan plc Retinal Disorders Treatment Introduction 11.1.4 Allergan plc Revenue in Retinal Disorders Treatment Business (2018-2023) 11.1.5 Allergan plc Recent Development 11.2 Bayer AG, F. 11.2.1 Bayer AG, F. Company Detail 11.2.2 Bayer AG, F. Business Overview 11.2.3 Bayer AG, F. Retinal Disorders Treatment Introduction 11.2.4 Bayer AG, F. Revenue in Retinal Disorders Treatment Business (2018-2023) 11.2.5 Bayer AG, F. Recent Development 11.3 Hoffmann-La Roche Ltd. 11.3.1 Hoffmann-La Roche Ltd. Company Detail 11.3.2 Hoffmann-La Roche Ltd. Business Overview 11.3.3 Hoffmann-La Roche Ltd. Retinal Disorders Treatment Introduction 11.3.4 Hoffmann-La Roche Ltd. Revenue in Retinal Disorders Treatment Business (2018-2023) 11.3.5 Hoffmann-La Roche Ltd. Recent Development 11.4 Graybug Vision, Inc. 11.4.1 Graybug Vision, Inc. Company Detail 11.4.2 Graybug Vision, Inc. Business Overview 11.4.3 Graybug Vision, Inc. Retinal Disorders Treatment Introduction 11.4.4 Graybug Vision, Inc. Revenue in Retinal Disorders Treatment Business (2018-2023) 11.4.5 Graybug Vision, Inc. Recent Development 11.5 Kubota Pharmaceutical Holdings Co., Ltd. 11.5.1 Kubota Pharmaceutical Holdings Co., Ltd. Company Detail 11.5.2 Kubota Pharmaceutical Holdings Co., Ltd. Business Overview 11.5.3 Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Introduction 11.5.4 Kubota Pharmaceutical Holdings Co., Ltd. Revenue in Retinal Disorders Treatment Business (2018-2023) 11.5.5 Kubota Pharmaceutical Holdings Co., Ltd. Recent Development 11.6 Novartis AG 11.6.1 Novartis AG Company Detail 11.6.2 Novartis AG Business Overview 11.6.3 Novartis AG Retinal Disorders Treatment Introduction 11.6.4 Novartis AG Revenue in Retinal Disorders Treatment Business (2018-2023) 11.6.5 Novartis AG Recent Development 11.7 Regeneron Pharmaceuticals, Inc. 11.7.1 Regeneron Pharmaceuticals, Inc. Company Detail 11.7.2 Regeneron Pharmaceuticals, Inc. Business Overview 11.7.3 Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Introduction 11.7.4 Regeneron Pharmaceuticals, Inc. Revenue in Retinal Disorders Treatment Business (2018-2023) 11.7.5 Regeneron Pharmaceuticals, Inc. Recent Development 11.8 Santen Pharmaceutical Co., Ltd. 11.8.1 Santen Pharmaceutical Co., Ltd. Company Detail 11.8.2 Santen Pharmaceutical Co., Ltd. Business Overview 11.8.3 Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Introduction 11.8.4 Santen Pharmaceutical Co., Ltd. Revenue in Retinal Disorders Treatment Business (2018-2023) 11.8.5 Santen Pharmaceutical Co., Ltd. Recent Development 11.9 Takeda Pharmaceutical Company Limited 11.9.1 Takeda Pharmaceutical Company Limited Company Detail 11.9.2 Takeda Pharmaceutical Company Limited Business Overview 11.9.3 Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Introduction 11.9.4 Takeda Pharmaceutical Company Limited Revenue in Retinal Disorders Treatment Business (2018-2023) 11.9.5 Takeda Pharmaceutical Company Limited Recent Development 11.10 Pfizer 11.10.1 Pfizer Company Detail 11.10.2 Pfizer Business Overview 11.10.3 Pfizer Retinal Disorders Treatment Introduction 11.10.4 Pfizer Revenue in Retinal Disorders Treatment Business (2018-2023) 11.10.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Retinal Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Gels Table 3. Key Players of Ointments Table 4. Key Players of Capsules & Tablets Table 5. Key Players of Eye Drops Table 6. Global Retinal Disorders Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Retinal Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Retinal Disorders Treatment Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Retinal Disorders Treatment Market Share by Region (2018-2023) Table 10. Global Retinal Disorders Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Retinal Disorders Treatment Market Share by Region (2024-2029) Table 12. Retinal Disorders Treatment Market Trends Table 13. Retinal Disorders Treatment Market Drivers Table 14. Retinal Disorders Treatment Market Challenges Table 15. Retinal Disorders Treatment Market Restraints Table 16. Global Retinal Disorders Treatment Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Retinal Disorders Treatment Market Share by Players (2018-2023) Table 18. Global Top Retinal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Treatment as of 2022) Table 19. Ranking of Global Top Retinal Disorders Treatment Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Retinal Disorders Treatment Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Retinal Disorders Treatment Product Solution and Service Table 23. Date of Enter into Retinal Disorders Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Retinal Disorders Treatment Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Retinal Disorders Treatment Revenue Market Share by Type (2018-2023) Table 27. Global Retinal Disorders Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Retinal Disorders Treatment Revenue Market Share by Type (2024-2029) Table 29. Global Retinal Disorders Treatment Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Retinal Disorders Treatment Revenue Market Share by Application (2018-2023) Table 31. Global Retinal Disorders Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Retinal Disorders Treatment Revenue Market Share by Application (2024-2029) Table 33. North America Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Retinal Disorders Treatment Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Retinal Disorders Treatment Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Retinal Disorders Treatment Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Retinal Disorders Treatment Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Retinal Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Retinal Disorders Treatment Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Retinal Disorders Treatment Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Retinal Disorders Treatment Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Retinal Disorders Treatment Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Retinal Disorders Treatment Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Retinal Disorders Treatment Market Size by Country (2024-2029) & (US$ Million) Table 48. Allergan plc Company Detail Table 49. Allergan plc Business Overview Table 50. Allergan plc Retinal Disorders Treatment Product Table 51. Allergan plc Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 52. Allergan plc Recent Development Table 53. Bayer AG, F. Company Detail Table 54. Bayer AG, F. Business Overview Table 55. Bayer AG, F. Retinal Disorders Treatment Product Table 56. Bayer AG, F. Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 57. Bayer AG, F. Recent Development Table 58. Hoffmann-La Roche Ltd. Company Detail Table 59. Hoffmann-La Roche Ltd. Business Overview Table 60. Hoffmann-La Roche Ltd. Retinal Disorders Treatment Product Table 61. Hoffmann-La Roche Ltd. Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 62. Hoffmann-La Roche Ltd. Recent Development Table 63. Graybug Vision, Inc. Company Detail Table 64. Graybug Vision, Inc. Business Overview Table 65. Graybug Vision, Inc. Retinal Disorders Treatment Product Table 66. Graybug Vision, Inc. Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 67. Graybug Vision, Inc. Recent Development Table 68. Kubota Pharmaceutical Holdings Co., Ltd. Company Detail Table 69. Kubota Pharmaceutical Holdings Co., Ltd. Business Overview Table 70. Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Product Table 71. Kubota Pharmaceutical Holdings Co., Ltd. Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 72. Kubota Pharmaceutical Holdings Co., Ltd. Recent Development Table 73. Novartis AG Company Detail Table 74. Novartis AG Business Overview Table 75. Novartis AG Retinal Disorders Treatment Product Table 76. Novartis AG Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 77. Novartis AG Recent Development Table 78. Regeneron Pharmaceuticals, Inc. Company Detail Table 79. Regeneron Pharmaceuticals, Inc. Business Overview Table 80. Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Product Table 81. Regeneron Pharmaceuticals, Inc. Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 82. Regeneron Pharmaceuticals, Inc. Recent Development Table 83. Santen Pharmaceutical Co., Ltd. Company Detail Table 84. Santen Pharmaceutical Co., Ltd. Business Overview Table 85. Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Product Table 86. Santen Pharmaceutical Co., Ltd. Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 87. Santen Pharmaceutical Co., Ltd. Recent Development Table 88. Takeda Pharmaceutical Company Limited Company Detail Table 89. Takeda Pharmaceutical Company Limited Business Overview Table 90. Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Product Table 91. Takeda Pharmaceutical Company Limited Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 92. Takeda Pharmaceutical Company Limited Recent Development Table 93. Pfizer Company Detail Table 94. Pfizer Business Overview Table 95. Pfizer Retinal Disorders Treatment Product Table 96. Pfizer Revenue in Retinal Disorders Treatment Business (2018-2023) & (US$ Million) Table 97. Pfizer Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Retinal Disorders Treatment Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Retinal Disorders Treatment Market Share by Type: 2022 VS 2029 Figure 3. Gels Features Figure 4. Ointments Features Figure 5. Capsules & Tablets Features Figure 6. Eye Drops Features Figure 7. Global Retinal Disorders Treatment Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Retinal Disorders Treatment Market Share by Application: 2022 VS 2029 Figure 9. Macular Degeneration Case Studies Figure 10. Diabetic Retinopathy Case Studies Figure 11. Diabetic Macular Edema Case Studies Figure 12. Others Case Studies Figure 13. Retinal Disorders Treatment Report Years Considered Figure 14. Global Retinal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 15. Global Retinal Disorders Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 16. Global Retinal Disorders Treatment Market Share by Region: 2022 VS 2029 Figure 17. Global Retinal Disorders Treatment Market Share by Players in 2022 Figure 18. Global Top Retinal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Treatment as of 2022) Figure 19. The Top 10 and 5 Players Market Share by Retinal Disorders Treatment Revenue in 2022 Figure 20. North America Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. North America Retinal Disorders Treatment Market Share by Country (2018-2029) Figure 22. United States Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Canada Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Retinal Disorders Treatment Market Share by Country (2018-2029) Figure 26. Germany Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. France Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. U.K. Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Italy Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Russia Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Nordic Countries Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Retinal Disorders Treatment Market Share by Region (2018-2029) Figure 34. China Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Japan Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. South Korea Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Southeast Asia Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. India Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Australia Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Retinal Disorders Treatment Market Share by Country (2018-2029) Figure 42. Mexico Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Brazil Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Retinal Disorders Treatment Market Share by Country (2018-2029) Figure 46. Turkey Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Saudi Arabia Retinal Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Allergan plc Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 49. Bayer AG, F. Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 50. Hoffmann-La Roche Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 51. Graybug Vision, Inc. Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 52. Kubota Pharmaceutical Holdings Co., Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 53. Novartis AG Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 54. Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 55. Santen Pharmaceutical Co., Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 56. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 57. Pfizer Revenue Growth Rate in Retinal Disorders Treatment Business (2018-2023) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Allergan plc Bayer AG, F. Hoffmann-La Roche Ltd. Graybug Vision, Inc. Kubota Pharmaceutical Holdings Co., Ltd. Novartis AG Regeneron Pharmaceuticals, Inc. Santen Pharmaceutical Co., Ltd. Takeda Pharmaceutical Company Limited Pfizer